The LHP Health Care Worker (HCW) Research Framework is a single streamlined process for the delivery of HCW research studies within the LHP region within community/primary care and secondary care settings.
The emergence of the COVID-19 pandemic is testing UK clinical and health care organisations, our workforce and our communities. Health Care Workers (HCW) have accounted for 4% of cases in China and 8% in Italy. The rate in the UK is unknown but as of 22 April 2020, 106 healthcare workers have died of COVID-19 in the UK, 0.5% of all COVID-19 related deaths with a disproportionate number of BAME staff.
NIHR Urgent Public Health (UPH) studies in HCW prevention strategies including prophylaxis and vaccination are in development, but HCW mental health has also been identified as an area of concern and area of need for research and interventions.
HCW infections and deaths have occurred across Merseyside and this is something that LHP and our members are keen to address by ensuring equity of access to research for staff across the LHP footprint in both community and hospital settings is vital. However, delivery of HCW studies must be done in a way that does not compromise the delivery of patient-focused research.
LHP HCW Research Framework provides the infrastructure to support the efficient set-up and delivery, across multiple sites, of National NIHR Urgent Public Health (UPH) and non-UPH studies (commercial and non-commercial) and locally strategic important LHP research studies focused on health care workers across the LHP footprint.
HCW research portfolio will include but not be restricted to:
LHP HCW Research Framework uses a ‘Hub and Spoke model’:
First study to open under the HCW Research Framework
COVID IMMUNITY STUDY ‘SIREN’ SET TO GET UNDERWAY WITHIN LIVERPOOL HEALTH PARTNERS NHS TRUST ORGANISATIONS WITHIN LHP, LIVERPOOL UNIVERSITY HOSPITAL NHS FOUNDATION TRUST (LUHFT), CLATTERBRIDGE CANCER CENTRE (CCC) and ALDER HEY CHILDREN’S HOSPITAL (AH) WILL BE OPENING TO THE SIREN STUDY SOON.
SIREN – SARS-COV2 immunity and reinfection evaluation observational study looking at the impact of detectable anti-SARS-COV2 antibody on the incidence of COVID-19 in healthcare workers (IRAS-Number: 284460; CPMS-ID: 45906; NIHR UPH Study)
Funder: Department of Health and Social Care
Sponsor: Public Health England
CI: Dr Susan Hopkins
All NHS staff who deliver care to patients can participate in the study and are being asked to have a nose and throat swab every other week in order to detect mild cases or cases who do not have symptoms. The study we will provide important information to help understand the future impact of COVID-19 on the population.
Information on how to participate in SIREN and other LHP participating sites will follow soon.